RMTI

Rockwell Medical, Inc. (NASDAQ:RMTI) is a biopharmaceutical company founded in 1996 and headquartered in Wixom, Michigan. The company went public in 1998 and has evolved from a diversified medical products company into a focused provider of hemodialysis concentrates and related products for kidney dialysis treatment. Over its nearly three-decade history, Rockwell has undergone significant strategic repositioning, particularly in recent years, transitioning away from drug development to concentrate on its core dialysis support business, which has become the second-largest supplier of dialysis concentrates in the United States.